Stay updated on AbbVie Press Releases

Sign up to get notified when there's something new on the AbbVie Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the AbbVie Press Releases page

  1. Check
    today
    Change Detected
    Summary
    Adds an August 27, 2026 news item announcing AbbVie’s EMA regulatory submission for SKYRIZI subcutaneous induction in adults with Crohn’s disease, along with related social posts and quick links. Also removes several older updates (e.g., Allergan Aesthetics privileges news and the Q2 2026 financial results post), altering the page’s current lineup of stories.
    Difference
    7%
    Check dated 2026-08-29T21:54:28.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Added two new News Center items for August 21 and August 18, 2026—covering WCLC 2026 data and the Immunology Scholarship recipients. Older posts and related links were removed from the feed (e.g., July 2026 posts and Learn more prompts).
    Difference
    9%
    Check dated 2026-08-22T22:06:26.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    An August 11, 2026 news item about Allergan Aesthetics Partner Privileges was added to the News Center. Older items, including the July 30, 2026 JUVÉDERM Day Returns to U.S. on August 19 post and an AbbVie Phase 3 results release for Epcoritamab, were removed from the listing.
    Difference
    2%
    Check dated 2026-08-15T18:55:10.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a new press release item about the FDA accepting Allergan Aesthetics' supplemental Biologics License Application for BOTOX Cosmetic for Masseter Muscle Prominence. Removed several older major announcements, including the European Commission approval for RINVOQ in Alopecia Areata and related updates.
    Difference
    3%
    Check dated 2026-08-08T15:43:42.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The News Center feed gained new items such as quarterly financial results, a regulatory approval announcement, and an earnings call link, while older social posts and notices were removed to clean up the feed.
    Difference
    12%
    Check dated 2026-08-01T12:04:58.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    A new AbbVie News Center item was added regarding clarification on the EPCORE DLBCL-1 trial; at the same time, several older press releases and social posts were removed or trimmed as part of a content refresh.
    Difference
    8%
    Check dated 2026-07-25T07:43:02.000Z thumbnail image

Stay in the know with updates to AbbVie Press Releases

Enter your email address, and we'll notify you when there's something new on the AbbVie Press Releases page.